+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Chronic Pain

Catalog No Product Description CAS No. Purity Structural Formula
SBP02918
Pellitorine
Pellitorine is a potential larvicide with a specific target site and a lead molecule for the control of mosquito populations, it also shows antiprotozoal activity against Plasmodium falciparum (IC50 = 3.3 ug/mL). Pellitorine shows potent antiplatelet aggregation activity, it can suppress expression of inducible NO synthase and cyclooxygenase-2. Pellitorine also shows strong cytotoxic activities against HL60 and MCT-7 cell lines. Pellitorine is a fatty amide. It has a role as a metabolite.
18836-52-7 98% Pellitorine
BP0999
N-Methylcytisine
N-Methylcytisine's nicotinic receptors have high affinity (KD = 50 nM)to nAChR from squid optical ganglia, N-methylcytisine is a selective ligand of nicotinic receptors of acetylcholine in the central nervous system. (−)-N-methylcytisine and (−)-anagyrine have nematicidal activity against pine wood nematodes.
486-86-2 98% N-Methylcytisine
BP4108
Hydroxy-γ-sanshool
Hydroxy-gamma-sanshool is a fatty amide.
78886-66-5 98% Hydroxy-γ-sanshool
SBP02579 1897-26-3 Akuammiline
BP4110
Hydroxyl-γ-isosanshool
N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide is a fatty amide.
127514-62-9 98% Hydroxyl-γ-isosanshool
BPI026 42046-35-5 98% Dosulepin impurity A
BP0398
Corynoline
Corynoline is a benzophenanthridine alkaloid that is chelidonine substituted by a methyl group at position 13. Isolated from the aerial parts of Corydalis incisa, it acts as an acetylcholinesterase inhibitor and also exhibits antineoplastic and hepatoprotective activity. It has a role as a metabolite, an antineoplastic agent, an EC 3.1.1.7 (acetylcholinesterase) inhibitor and a hepatoprotective agent. Corynoline is a reversible and noncompetitive inhibitor of acetylcholinesterase(AChE) with the IC50 value of 30.6 microM, which exhibits the potent anti-inflammatory and/or immunosuppressive activity, the potent inhibitory activity of corynoline for the ICAM-1/LFA-1 adhesion and would be important on developing the clinically usable drugs for the inflammatory diseases.
18797-79-0 98% Corynoline
BP4112 10076-00-3 β-Sanshool
BP4863 70342-29-9 98% Methyl kakuol
SBP02251 64052-90-0 Cannabispirol
SBP00071 110414-77-2 Gelsemiol
BP0032
1-Monomyristin
1-Monomyristin is a 1-monoglyceride with tetradecanoyl (myristoyl) as the acyl group. It has a role as a Caenorhabditis elegans metabolite. It is a 1-monoglyceride and a tetradecanoate ester. 1-Monomyristin was extracted from Serenoa repens and inhibited the hydrolysis of 2-oleoyl glycerol (IC50=32 μ M) and the activity of fatty acid amide hydrolase (FAAH) (IC50=18 μ M). 1-Monomyristin has antibacterial activity against Staphylococcus aureus and actinomycetes, as well as antifungal activity against Candida albicans.
589-68-4 98% 1-Monomyristin
BP4109 252193-26-3 Hydroxy-ε-sanshool
BP2202 1247014-34-1 98% Volvalerenic acid A
BPC0170 501-33-7 8-Azabicyclo-3.2.1-octan-3-ol
SBP01548 1042143-83-8 Yunnandaphninine G
BP4739
Valerenic acid
Valerenic acid is a monocarboxylic acid that is 2-methylprop-2-enoic acid which is substituted at position 3 by a 3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl group. A bicyclic sesquiterpenoid constituent of the essential oil of the Valerian plant. It has a role as a volatile oil component, a sedative, a GABA modulator and a plant metabolite. It is a monocarboxylic acid, a sesquiterpenoid and a carbobicyclic compound. It is a conjugate acid of a valerenate. Valerenic acid, a subunit specific allosteric modulator of GABAA receptors, has anxiolytic, and antioxidant activities.
3569-10-6 98% Valerenic acid
BP4111 504-97-2 α-Sanshool
BP0049
(±)-Borneol
(±)-Borneol is a bornane monoterpenoid that is 1,7,7-trimethylbicyclo[2.2.1]heptane substituted by a hydroxy group at position 2. It has a role as a metabolite and a volatile oil component.(±)-Borneol is a bornane monoterpenoid that is 1,7,7-trimethylbicyclo[2.2.1]heptane substituted by a hydroxy group at position 2. It has a role as a metabolite and a volatile oil component. (±)-Borneol is a bicyclic monoterpene used for analgesia and anaesthesia in traditional Chinese and Japanese medicine, it and its enantiomer (±)-Borneol have a highly efficacious positive modulating action at GABA(A) receptors at human recombinant alpha1beta2gamma2L GABA(A) receptors. Borneol specifically inhibits the nicotinic acetylcholine receptor (nAChR)-mediated effects in a noncompetitive way, can depress P-glycoprotein function by a NF-κB signaling mediated mechanism in a blood brain barrier in vitro model. Borneol has neuroprotection through the inhibition of IκBα-NF-κB and translocation signaling pathway, it also has an anti-cerebral ischemia effects. It can suppresse inflammatory responses in LPS-induced acute lung injury through inhibition of the NF-κB and MAPKs signaling pathways.
507-70-0 98% (±)-Borneol
BP1831 98% Macamide Impurity 9